DNA nanotherapeutics facilitate efficient gynecological cancers treatment
Journal of Controlled Release · 2025
DOI: 10.1016/j.jconrel.2025.114336 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Xiaohan Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Nanomedical Technology (Education Department of Fujian Province), Department of Pharmaceutical Analysis, School of Pharmacy, Fujian…. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, DNA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 163 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fujian Medical University, Fujian Provincial Health Technology Project.
Abstract (Originalsprache)
Gynecological cancers, including ovarian, cervical, and endometrial cancers, remain major global health challenges. Conventional therapies such as surgery, chemotherapy, and radiotherapy exhibit substantial limitations, including severe systemic toxicity and the emergence of therapeutic resistance, leading to poor patient outcomes. DNA nanotherapeutics present a transformative approach by integrating the programmability and versatility of DNA with the advantages of nanotechnology, enabling precise and effective interventions. These systems function as both therapeutics and carriers, facilitating targeted treatment through diverse approaches such as DNA vaccines, gene editing, protein restoration, and DNA nanoplatforms. DNA vaccines have shown promise in generating robust immune responses against HPV-related cervical cancer and tumor-associated antigens in ovarian and endometrial cancers. Gene-editing technologies, particularly CRISPR/Cas9, offer a precise means to correct oncogenic mutations and restore tumor suppressor functions. Furthermore, DNA nanotherapeutics enable protein restoration by delivering therapeutic DNA encoding tumor suppressors, such as p53 and PTEN, to reestablish their critical roles in cell cycle regulation and apoptosis. DNA origami and platforms enhance therapeutic precision by enabling controlled, site-specific delivery of therapeutic payloads, improving treatment efficacy and minimizing off-target effects. Despite these advances, challenges remain in achieving efficient in vivo delivery, overcoming tumor heterogeneity, and manufacturing scalability. This review provides a comprehensive analysis of DNA nanotherapeutics for gynecological cancer treatment, highlighting their potential to revolutionize cancer therapy through precise, personalized, and multimodal interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Nanomedical Technology (Education Department of Fujian Province), Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China; Department of Obstetrics &…
- Center for Nanomedicine and Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: yzhang169@bwh.harvard.edu.
- Key Laboratory of Nanomedical Technology (Education Department of Fujian Province), Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China; School of Medical Imaging,…
Förderung
- National Natural Science Foundation of China
- Fujian Medical University
- Fujian Provincial Health Technology Project
- Natural Science Foundation of Fujian Province
- China Postdoctoral Science Foundation
Zitieren
APA
Zheng, X., Zhuang, J., Peng, X., Zhang, Y., Chen, D., & Chen, B. (2025). DNA nanotherapeutics facilitate efficient gynecological cancers treatment. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.114336
Vancouver
Zheng X, Zhuang J, Peng X, Zhang Y, Chen D, Chen B. DNA nanotherapeutics facilitate efficient gynecological cancers treatment. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2025.114336
BibTeX
@article{Zheng2025,
author = {Zheng, Xiaohan and Zhuang, Jingying and Peng, Xinyan and Zhang, Yang and Chen, Dezhao and Chen, Bing},
title = {DNA nanotherapeutics facilitate efficient gynecological cancers treatment},
journal = {Journal of Controlled Release},
year = {2025},
doi = {10.1016/j.jconrel.2025.114336}
}
EUVIMED